BioPharmGuy logo
Sponsored By:
Trianni Inc.
BioPharmGuy Database
Emery Pharma
Ceptaris Therapeutics is defunct.

Fate: Bought by Actelion, Sept 2013, $250M


------------------
If you believe any of this information is incorrect, please let us know.